Rheumatology International

期刊全称Rheumatology International
期刊缩写RHEUMATOL INT
涉及主题医学内科学生物心理学病理精神科放射科免疫学痹症科外科遗传学疾病化学类风湿性关节炎生物化学内分泌学关节炎胃肠病学数学物理疗法皮肤病科
期刊介绍

RHEUMATOLOGY INTERNATIONAL is an independent journal reflecting world-wide progress in the research, diagnosis and treatment of the various rheumatic diseases. It is designed to serve researchers and clinicians in the field of rheumatology. RHEUMATOLOGY INTERNATIONAL will cover all modern trends in clinical research as well as in the management of rheumatic diseases. Special emphasis will be given to public health issues related to rheumatic diseases, applying rheumatology research to clinical practice, epidemiology of rheumatic diseases, diagnostic tests for rheumatic diseases, patient reported outcomes (PROs) in rheumatology and evidence on education of rheumatology. Contributions to these topics will appear in the form of original publications, short communications, editorials, and reviews. "Letters to the editor" will be welcome as an enhancement to discussion. Basic science research, including in vitro or animal studies, is discouraged to submit, as we will only review studies on humans with an epidemological or clinical perspective. Case reports without a proper review of the literatura (Case-based Reviews) will not be published. Every effort will be made to ensure speed of publication while maintaining a high standard of contents and production. Manuscripts submitted for publication must contain a statement to the effect that all human studies have been reviewed by the appropriate ethics committee and have therefore been performed in accordance with the ethical standards laid down in an appropriate version of the 1964 Declaration of Helsinki. It should also be stated clearly in the text that all persons gave their informed consent prior to their inclusion in the study. Details that might disclose the identity of the subjects under study should be omitted.

期刊ISSNprint: 0172-8172
历年影响因子
2024年 2023年 2022年 2021年 2020年 2019年 2018年 2017年
3.243.582.6311.9842.21.9521.824
历年发表/被引量
年份20252024202320222021202020192018201720162015201420132012
发表量143247249202301252275307278226209271302303
被引量4378114101231812789128721093291318104790971617549726467575633
h-Index66
自引率6.20%
涉及的研究领域医学-风湿病学
中科院2025年分区 ?
大类小类TOP期刊综述期刊
3区4区 风湿病学
WOS期刊分区

JCR学科分类

JCR分区学科名称收录数据库JCR分区分区排名
RHEUMATOLOGYSCIEQ220/58

JCI学科分类

JCI分区学科名称收录数据库JCI分区分区排名
RHEUMATOLOGYSCIEQ222/58
期刊主页https://www.springer.com/296https://www.springer.com/journal/296
投稿网址https://www.editorialmanager.com/rhei/
出版商Springer Berlin Heidelberg
出版国家(地区)GERMANY
出版语言English
出版周期Tri-annual
每年出版文章数280
Gold OA文章占比30.03%
原创研究文献占比
(排除综述)
67.69%
SCI收录类型

Science Citation Index Expanded (SCIE)

Scopus (CiteScore)

PubMed链接http://www.ncbi.nlm.nih.gov/nlmcatalog?term=0172-8172%5BISSN%5D
平均审稿周期平均16.月
平均录用比例约75%
相关链接

您可以在上述网站查看该期刊的网友互动,及期刊影响力的其它指标。

注:上述信息均来源于网络,仅供查考,如有遗漏或信息错误,欢迎 向我反馈